Patient survival after hip arthroplasty for metastatic disease of the hip

Journal of Bone and Joint Surgery

Volumn 86, Issue 8, 2004, Pages 1684-1689

  Schneiderbauer, Michaela M ^a   Von Knoch, Marius ^b   Schleck, Cathy D ^a   Harmsen, William S ^a   Sim, Franklin H ^a   Scully, Sean P ^a  

^a MAYO CLINIC   (United States)

^b Orthopaedie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SURVIVAL; FEMALE; HIP; HIP ARTHROPLASTY; HIP DISEASE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 3543028616     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200408000-00011     Document Type: Review

References (20)

1. Harrington KD. Orthopaedic management of metastatic bone disease. St. Louis: Mosby; 1988.
2. Buckwalter JA, Brandser EA. Metastatic disease of the skeleton. Am Fam Physician. 1997;55:1761-8.
3. Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am. 2000;31:515-28.
4. Habermann ET, Sachs R, Stern RE, Hirsh DM, Anderson WJ Jr. The pathology and treatment of metastatic disease of the femur. Clin Orthop. 1982;169:70-82.
5. Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am. 1980;62:954-9.
6. Harrington KD, Johnston JO, Turner RH, Green DL. The use of methylmethacrylate as an adjunct in the internal fixation of malignant neoplastic fractures. J Bone Joint Surg Am. 1972;54:1665-76.
7. Algan SM, Horowitz SM. Surgical treatment of pathologic hip lesions in patients with metastatic disease. Clin Orthop. 1996;332:223-31.
8. Clarke HD, Damron TA, Sim FH. Head and neck replacement endoprosthesis for pathologic proximal femoral lesions. Clin Orthop. 1998;353:210-7.
9. Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am. 2000;82:642-51.
10. Wedin R, Bauer HC, Rutqvist LE. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer. 2001;92:257-62.
11. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143-6.
12. McGrory BJ, Morrey BF, Rand JA, Ilstrup DM. Correlation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty. A prospective study of 201 joint arthroplasties. J Arthroplasty. 1996;11:47-57.
13. Kaplan EL, Meler P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
14. Cox DR. Regression models and life-tables [with discussion]. J Roy Statist Soc Series B. 1972;34:187-202.
15. Jung ST, Ghert MA, Harrelson JM, Scully SP. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop. 2003;409:223-31.
16. McBroom RJ, Cheal EJ, Hayes WC. Strength reductions from metastatic cortical defects in long bones. J Orthop Res. 1988;6:369-78.
17. Leggon RE, Lindsey RW, Panjabi MM. Strength reduction and the effects of treatment of long bones with diaphyseal defects involving 50% of the cortex. J Orthop Res. 1988;6:540-6.
18. Keene JS, Sellinger DS, McBeath AA, Engber WD. Metastatic breast cancer in the femur. A search for the lesion at risk of fracture. Clin Orthop. 1986;203:282-8.
19. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop. 1989;249:256-64.
20. Damron TA, Sim FH. Operative treatment for metastatic disease of the pelvis and the proximal end of the femur. J Bone Joint Surg Am. 2000;82:114-26.